| Autor: |
Zahr RS; Division of Pediatric Nephrology and Hypertension, University of Tennessee Health Science Center Memphis, TN. rzahr@uthsc.edu., Rashkin SR; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN., Ruiz MA; Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL., Elsherif L; Center for Sickle Cell Disease, University of Tennessee Health Sciences Center, Memphis, TN., Ren G; Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL., Salas G; Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL., Ataga KI; Center for Sickle Cell Disease, University of Tennessee Health Sciences Center, Memphis, TN., Gordeuk VR; Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL., Lebensburger J; Division of Pediatric Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL., Zhang X; Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL., Saraf SL; Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL. ssaraf@uic.edu. |
